Czech e-Rxing meets opposition, disinterest

2 July 2006

The introduction of electronic prescriptions has met with opposition and indifference in the Czech Republic. The new European Union member state has become the latest European country to introduce e-prescriptions following an amendment to health care legislation this month.

But critics say it has been rushed through and does not go far enough. "This new form of e-prescription is absolutely nonsensical. All it does is make it possible for hospital doctors to send a prescription electronically to a hospital pharmacy," said Lubomir Chudoba, director of the Czech Pharmacists Chamber. "We as a chamber very much support the principle of e-prescriptions, but this amendment doesn't go nearly far enough. It needs to be a widespread scheme that helps patients, doctors and pharmacies," Dr Chudoba added.

Various confusing systems in play

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight